Artículo

Glyceollin I enantiomers distinctly regulate ER-mediated gene expression

Payton Stewart, Florastina ; Khupse, Rahul S. ; Boue, Stephen M. ; Elliot, Steven ; Zimmermann, Maria Carla Icon; Skripnikova, Elena V. ; Ashe, Hasina ; Tilghman, Syreeta L. ; Beckman, Barbara S. ; Cleveland, Thomas E. ; McLachlan, John A. ; Bhatnagar, Deepak ; Wiese, Thomas E. ; Erhardt, Paul ; Burow, Matthew E.

Otros responsables

Fecha

12/2010

Editorial

Elsevier Science Inc

Revista

Steroids

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0039-128X

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Glyceollins are pterocarpan phytoalexins elicited in high concentrations when soybeans are stressed. We have previously reported that the three glyceollin isomers (GLY I-III) exhibit antiestrogenic properties, which may have significant biological effects upon human exposure. Of the three isomers, we have recently shown that glyceollin I is the most potent antiestrogen. Natural (-)-glyceollin I recently was synthesized along with its racemate and unnatural (+) enantiomer. In this study, we compared the glyceollin I enantiomers' ER binding affinity, ability to inhibit estrogen responsive element transcriptional (ERE) activity and endogenous gene expression in MCF-7 cells. The results demonstrated similar binding affinities for both ERα and ERβ. Reporter gene assays in MCF-7 cells revealed that while (+)-glyceollin I slightly stimulated ERE transcriptional activity, (-)-glyceollin I decreased activity induced by estrogen. Co-transfection reporter assays performed in HEK 293 cells demonstrated that (+)-glyceollin I increased ERE transcriptional activity of ERα and ERβ with and without estrogen with no antiestrogenic activity observed. Conversely, (-)-glyceollin I decreased the activity of both ER subtypes stimulated by estradiol demonstrating potent antiestrogenic properties. Additionally, each Gly I enantiomer induced unique gene expression profiles in a PCR array panel of genes commonly altered in breast cancer.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa